NovaBay Pharma up on data showing antimicrobial spray effective against coronavirus

Stablecoin Development

13/07/2020 13:33

** Shares of biopharmaceutical company  NBY.A  rise 38% to
$1.56 premarket
    ** Co says test carried out by an independent third-party
lab confirms that NBY's antimicrobial solution of FDA-cleared
hypochlorous acid, Avenova, kills SARS-CoV-2 that causes
COVID-19  urn:newsml:reuters.com:*:nBw9Lt4FRa
    ** Study proves Avenova's ability to fully inactivate the
virus on a hard surface at 60 secs - NBY
    ** Test data will be submitted to Environmental Protection
Agency (EPA) for inclusion in agency's approved list of
disinfectants for use against SARS-CoV-2
    ** Shares up ~77% this year, up to last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))